Potential Therapeutic Targets for Cardiac Fibrosis
Indexed incrossrefpubmed
Abstract
Fibrosis is one of the largest groups of diseases for which there is no therapy but is believed to occur because of a persistent tissue repair program. During connective tissue repair, "activated" fibroblasts migrate into the wound area, where they synthesize and remodel newly created extracellular matrix. The specialized type of fibroblast responsible for this action is the alpha-smooth muscle actin (alpha-SMA)-expressing myofibroblast. Abnormal persistence of the myofibroblast is a hallmark of fibrotic diseases. Proteins such as transforming growth factor (TGF)beta, endothelin-1, angiotensin II (Ang II), connective tissue growth factor (CCN2/CTGF), and platelet-derived growth factor (PDGF) appear to act in a…
Citation impact
668
total citations
- FWCI
- 21.64
- Percentile
- 100%
- References
- 71
Citations per year
Authors
1Topics & keywords
Topics
Keywords
- Cardiac fibrosis
- Fibrosis
- Medicine
- Cardiology
- Intensive care medicine
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.